Nektar Therapeutics (NASDAQ:NKTR) Given Market Perform Rating at William Blair
William Blair reaffirmed their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note released on Monday morning,RTT News reports. Several other equities research analysts have also recently issued reports on NKTR. Jefferies Financial Group upgraded Nektar Therapeutics from a “hold” rating to a “buy” rating and boosted their […]
William Blair reaffirmed their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note released on Monday morning,RTT News reports. Several other equities research analysts have also recently issued reports on NKTR. Jefferies Financial Group upgraded Nektar Therapeutics from a “hold” rating to a “buy” rating and boosted their […]
